| Patient | Ernest Hemingway |
|---|---|
| Date of birth | 1970-07-21 |
| Identifiers | MRN HR-ET003-SYN; SSN (made up) 000-03-7419 |
| Document date | 2026-03-16 |
| Author | Ingrid Solheim, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Raised transferrin saturation and ferritin with raised liver enzymes in a 55-year-old man with severe alcohol use disorder. Please advise on the cause, whether and how to stage his liver, and treatment. [S]
Urgency: Within two weeks, on the same day as his two-week primary care visit. [S]
Questions for the consultant:
Mr. Hemingway, a 55-year-old writer, is seen at the request of Dr. Brandt-Ochoa. He has drunk heavily for many years and has cut down from about ten drinks a day to five or six in the two weeks since he started naltrexone. A year ago, in two plane crashes, he had a concussion with a skull fracture and injuries to his right kidney, liver and spleen; he was not told of any lasting liver damage. He has no jaundice, abdominal swelling, bleeding, confusion or joint pain in his hands. He takes no iron, vitamin C or other supplements and eats raw oysters now and then. He has not been told of hemochromatosis in his family. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
8 later historical claims are omitted because they describe events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Naltrexone 50 mg oral tablet, one tablet daily, to reduce heavy drinking | One tablet daily | Oral route | 2026-03-02 | active | S |
| Thiamine 100 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-03-02 to 2026-08-31 | completed | S |
| Sertraline 50 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-03-02 to 2026-04-13 | completed | S |
| Amlodipine 5 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-03-02 to 2026-06-08 | completed | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Alcohol use disorder, severe; heavy daily drinking for most of his adult life; synthetic modern episode linked to his documented heavy drinking | active | confirmed | F10.20 | S — Synthetic modern coding of DSM-5-TR severe alcohol use disorder (seven criteria); person-first language; not a claim about his real diagnosis. |
| Raised transferrin saturation and ferritin found on routine intake tests, cause not yet known (heavy drinking, liver disease or iron overload) | resolved | confirmed | R79.0 | S — Synthetic presenting finding; superseded when HFE testing gave the diagnosis. |
| Hereditary hemochromatosis, HFE C282Y homozygous, with iron overload (ferritin over 1,000 ng/mL) and no advanced liver fibrosis on imaging | active | confirmed | E83.110 | S — Synthetic modern diagnosis. Whether he had hemochromatosis is disputed (CLM-0013); the modern diagnosis is not offered as proof of it. |
| Major depressive disorder, single episode, moderate; Mood Disorder Questionnaire negative and no history of mania or hypomania | active | confirmed | F32.1 | S — Synthetic modern diagnosis; not a claim about his real mood. The roster's bipolar disorder lead is disputed (CLM-0014) and is not used. |
| Essential hypertension, stage 2, with heavy drinking contributing | active | confirmed | I10 | S — Synthetic modern diagnosis confirmed by home readings. |
| Post-concussion symptoms (headaches, slowed thinking and forgetfulness) after repeated head injuries, most recently a concussion with a skull fracture a year ago; chronic traumatic encephalopathy is not diagnosed | active | confirmed | F07.81 | S — Synthetic modern diagnosis anchored to his documented head injuries; alcohol and depression also affect the symptoms. |
| Prediabetes (HbA1c 6.1%) | active | confirmed | R73.03 | S — Synthetic finding on diabetes screening; iron overload and alcohol both raise the risk of diabetes. |
Vital signs recorded on 2026-03-16; see the referring visit's Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; no smell of alcohol; blood pressure 144/90 |
| Abdomen | Liver edge 1 cm below the costal margin, smooth and non-tender; no spleen felt; no ascites |
| Skin | No jaundice, spider naevi, palmar erythema or bronze pigmentation |
| Musculoskeletal | No swelling or tenderness of the second and third knuckles |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-03-16 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 58 | U/L | 10-40 U/L | High | S |
| 2026-03-16 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 66 | U/L | 7-55 U/L | High | S |
| 2026-03-16 | Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma | 160 | U/L | 8-61 U/L | High | S |
| 2026-03-16 | Ferritin [Mass/volume] in Serum or Plasma | 1395 | ng/mL | 24-336 ng/mL | High | S |
| 2026-03-16 | Liver stiffness by US.transient elastography | 9.4 | kPa | Below 7.0 kPa makes significant fibrosis unlikely; 12.5 kPa or more suggests cirrhosis | High | S |
Data reviewed: Dr. Brandt-Ochoa's intake note and today's two-week note. HFE genotype: C282Y homozygous. Intake: transferrin saturation 76%, serum iron 214 ug/dL, ferritin 1,460 ng/mL; AST 70, ALT 78 and GGT 196 U/L; bilirubin 1.0 mg/dL; albumin 4.1 g/dL; platelets 208; MCV 102 fL; HbA1c 6.1%; HIV, hepatitis B and hepatitis C nonreactive. Today: ferritin 1,395 ng/mL; AST 58, ALT 66 and GGT 160 U/L. Transient elastography in clinic today: liver stiffness 9.4 kPa, controlled attenuation parameter 288 dB/m. [S]